Natural immunodominant peptide fragment (209-217) derived from the gp 100 melanoma-associated antigen that shows intermediate binding affinity with the HLA-A2 molecule. It perhaps may be useful in the development of novel cancer immunotherapies. MW: 890.05 Da. Purity >98 % purified